[Prevention and treatment of leg vein thrombosis in obstetrics and gynecology].
After a short introduction concerning the pathophysiology of thrombosis and the historical development of the anticoagulant therapy the indications and the clinical experiences of the antithrombotic therapy in the field of obstetrics and gynaecology are described. The treatment of the thrombosis of the femoral veins and the methods of the therapy control are described.
D000273:Adipose Tissue / Q000473:pathology; D000925:Anticoagulants / Q000627:therapeutic use*; D003374:Coumarins / Q000009:adverse effects / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005831:Genital Diseases, Female / Q000601:surgery*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D007866:Leg / Q000098:blood supply*; D009336:Necrosis / Q000139:chemically induced; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy / Q000517:prevention & control*; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy / Q000517:prevention & control*
D000925:Anticoagulants; D003374:Coumarins; D003911:Dextrans; D005343:Fibrinolytic Agents; D007189:Indans; D006493:Heparin; D013300:Streptokinase
Prophylaxe und Therapie der Beinvenenthrombose in Geburtshilfe und Gynäkologie.